Recently, an important congress for pulmonary and respiratory medicine had started with 3,000 participants at the Congress Center Leipzig. Until Saturday, more than 120 symposia and poster presentations will discuss current topics and the latest findings from the wide-ranging field of pneumology. Around 600 top-class scientists will present their latest research findings.
“Of course, we also discuss all relevant topics related to COVID-19 and consider how we as physicians prepare for the next winter. Most importantly, we talk about what challenges we will face in pneumology in the coming years and decades.”
- Professor Stefan Kluge, President of the Congress of the German Society of Pneumology and Respiratory Medicine (DGP)
The keynote speech by Professor Lothar H. Wieler is also eagerly awaited. On Thursday evening, the president of the Robert Koch Institute will shed light on the past pandemic years and the knowledge that has been gained about Sars-CoV‑2. “I am very pleased that the most important figures in our field are sharing their current research findings with all of us,” says Professor Torsten Bauer, President of the DGP. Development and progress: accents in intensive care and respiratory medicine The DGP Congress is themed “Development and Progress” — leading scientists will bring participants up to date on the latest research as well as clinical applications.
“As an intensive care physician, I have also set some accents on the topic of intensive and respiratory medicine at this congress, as this area has a special role to play due to the corona pandemic,” said congress president Kluge, director of the Department of Intensive Care Medicine at the University Medical Center Hamburg-Eppendorf. “For me, an important component of the congress is also the targeted work with young scientists and the approximately 20 postgraduate courses and workshops with which the event started today.”
A special highlight of the Pneumology Congress will be the seven high-profile presidential symposia, in which key topics will be examined in greater detail. There, the topics include tobacco cessation, vaccination for pneumological infections, developments in pulmonary hypertension, oxygen therapy, ventilation concepts and digitalization in pneumology — and there will be an update on COVID-19. “Here, too, all participants will have the opportunity to exchange ideas directly with the leading representatives of their respective research fields,” says Kluge. Short-term attendees can still register on the congress website on the days of the event. Selected program content — including all presidential symposia — will also be streamed live and available on demand for three months afterwards.
Research funding: the most important pneumology prizes will be awarded The most important prizes in the field of pneumology will also be awarded at the DGP Congress. On Thursday evening, the two DGP Research Prizes, each worth 10,000 euros, will be awarded in recognition of outstanding work in basic and clinical research. On Friday at noon, the prestigious Oskar Medicine Prize of the Oskar-Helene-Heim Foundation will be awarded — with 50,000 euros in funding, this is one of the most highly endowed medical prizes in Germany.
Be there: on site in Leipzig or digitally via livestream. Register online now via the DGP congress website! The German Society for Pneumology and Respiratory Medicine (DGP) is a scientific and medical society that specializes in improving the prevention, diagnosis and treatment of respiratory and lung diseases.
For a long time, the focus was on tuberculosis, but since the 1960s, widespread diseases such as asthma, the permanent respiratory disease COPD, pneumonia and lung cancer have made pneumology one of the major focus areas of internal medicine. Important current topics include smoking cessation, the effects of air pollutants on respiratory air, sleep-related respiratory disorders, ventilator weaning, and the novel coronavirus SARS-CoV‑2 and the resulting infectious disease COVID-19. The DGP was founded in 1910 and today has about 4,600 members from medicine and research.